As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL
The data presented so far, however, strongly suggests that retatrutide could become a transformative therapy in the fight against obesity
When it comes to weight loss, many people believe that lower-calorie goals are more effective
WeightWatchers Clinic's licensed medical providers can prescribe GLP-1 medication like Wegovy, Saxenda, or Zepbound
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a leading treatment in the fields of diabetes and obesity, with recent preclinical and clinical studies indicating significant benefits in the management and treatment of MASLD
Beyond the glossy interface, savvy visitors appreciate transparent terms, fair wagering rules, and banking options that fit their routine